Takeda Pharmaceutical Li...
13.05
0.06 (0.46%)
At close: Jan 14, 2025, 3:59 PM
13.04
-0.08%
After-hours Jan 14, 2025, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Revenue 4,263.80B 4,027.50B 3,569.00B 3,197.80B 3,291.20B 2,097.20B 1,770.50B 1,732.10B 1,807.40B 1,777.80B 1,691.70B 1,557.30B 1,508.90B 1,419.40B 1,466.00B 1,538.30B 1,374.80B 1,305.20B 1,212.20B 1,123.00B 1,086.40B 1,046.10B 1,005.10B 963.48B 923.13B
Cost of Revenue 1,431.50B 1,244.10B 1,106.80B 994.31B 1,089.80B 659.69B 495.92B 558.75B 535.40B 520.99B 490.26B 447.63B 433.19B 317.58B 285.06B 289.54B 278.63B 279.66B 282.10B 279.18B 269.39B 300.34B 337.85B 384.01B 432.33B
Gross Profit 2,832.30B 2,783.40B 2,462.20B 2,203.50B 2,201.40B 1,437.50B 1,274.60B 1,173.30B 1,272.00B 1,256.80B 1,201.40B 1,109.60B 1,075.70B 1,101.80B 1,180.90B 1,248.80B 1,096.20B 1,025.50B 930.11B 843.78B 817.04B 745.74B 667.21B 579.47B 490.80B
Operating Income 214.07B 490.50B 460.84B 509.27B 100.41B 204.97B 241.79B 155.87B 130.83B -129.25B 139.27B 122.50B 265.03B 367.08B 420.21B 306.47B 423.12B 458.50B 402.81B 385.28B 371.63B 310.69B 281.24B 226.10B 171.44B
Interest Income 11.29B 62.91B 23.70B 105.52B 27.83B 6.62B 39.54B 12.27B 21.64B 15.36B 49.30B 16.30B 6.30B 1.73B 1.98B 11.38B 62.06B 56.24B 34.21B 18.10B 10.90B 10.13B 9.61B 9.93B n/a
Pretax Income 52.79B 375.09B 302.57B 366.24B -60.75B 94.90B 217.21B 143.35B 120.54B -145.44B 158.85B 129.71B 252.48B 371.57B 415.83B 398.55B 576.84B 625.38B 517.96B 441.10B 446.14B 431.90B 373.43B 263.08B 202.76B
Net Income 144.07B 317.02B 230.06B 376.00B 44.24B 109.13B 186.89B 114.94B 80.17B -145.78B 106.66B 131.24B 124.16B 247.87B 297.74B 234.38B 355.45B 335.81B 313.25B 277.44B 285.26B 271.76B 235.66B 146.85B 119.63B
Selling & General & Admin 1,053.80B 997.31B 886.36B 875.66B 964.74B 717.60B 628.11B 619.06B 650.77B 612.61B 556.21B 987.13B 810.71B 734.72B 760.69B 942.33B n/a n/a n/a n/a n/a n/a 385.96B n/a 319.36B
Research & Development 729.92B 633.33B 526.09B 455.83B 492.38B 368.30B 325.44B 312.30B 345.93B 382.10B 341.56B 324.29B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses 834.44B -9.47B 588.87B 1,409.40B 1,434.30B 908.87B 707.38B 705.13B 795.22B 1,004.00B 720.59B 5.81B n/a 3.78B 735.00M 12.13B 673.05B 567.00B 527.30B 458.50B 445.40B 435.05B n/a 353.37B n/a
Operating Expenses 2,618.20B 2,292.90B 2,001.30B 1,694.20B 2,101.00B 1,277.20B 1,032.80B 1,017.40B 1,141.10B 1,386.10B 1,062.10B 987.13B 810.71B 734.72B 760.69B 942.33B 673.05B 567.00B 527.30B 458.50B 445.40B 435.05B 385.96B 353.37B 319.36B
Interest Expense 153.63B 169.70B 166.61B 248.63B 165.01B 48.16B 31.93B 23.25B 31.93B 32.88B 30.72B 3.32B 1.88B 1.33B 1.43B 1.62B 333.00M 247.00M 365.00M 334.00M 359.00M 420.00M 759.00M 1.02B 1.19B
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a 113.21B 105.25B 175.52B n/a 94.52B 94.01B 108.10B n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 4,049.70B 3,537.00B 3,108.20B 2,688.50B 3,190.80B 1,936.90B 1,528.70B 1,576.20B 1,676.50B 1,907.10B 1,552.40B 1,434.80B 1,243.90B 1,052.30B 1,045.80B 1,231.90B 951.68B 846.67B 809.40B 737.68B 714.80B 735.39B 723.82B 737.38B 751.69B
Income Tax -91.41B 58.05B 72.41B -9.94B -105.04B -14.12B 30.50B 27.83B 37.06B -2.40B 49.29B -3.88B 125.21B 121.33B 115.67B 161.35B 218.77B 285.84B 201.36B 160.23B 157.91B 157.49B 134.89B 114.15B 81.45B
Shares Outstanding (Basic) 1.56B 1.55B 1.56B 1.56B 1.56B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B
Shares Outstanding (Diluted) 1.58B 1.57B 1.58B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B 1.57B
EPS (Basic) 92.09 204.29 147.14 240.72 28.41 69.57 239.35 147.15 102.26 -92.94 135.10 188.21 157.29 314.01 377.19 289.82 418.97 386.00 353.47 313.01 321.86 307.63 267.02 166.39 135.55
EPS (Diluted) 91.16 201.94 145.87 238.96 28.25 69.57 237.55 146.26 101.71 -92.94 134.95 188.17 157.26 313.96 377.14 289.80 418.97 386.00 353.47 313.01 321.86 307.63 267.02 166.39 135.55
EBITDA 874.60B 1,184.50B 1,183.20B 983.72B 880.33B 464.22B 359.96B 296.88B 349.85B 57.29B 368.18B 351.18B 404.56B 479.63B 532.08B 518.25B 608.87B 654.45B 547.05B 472.66B 474.59B 462.28B 402.62B 297.70B 237.32B
Depreciation & Amortization 728.00B 664.40B 583.15B 559.67B 583.65B 247.69B 182.13B 171.43B 197.38B 260.95B 215.74B 201.11B 150.19B 106.72B 114.83B 118.08B 31.69B 28.82B 28.73B 31.23B 28.08B 29.96B 28.43B 33.60B 33.36B

Create Price Alert on TAK

Your price alert will notify you when the stock price is above 13.05.

Add to Watchlist